Stephenson Harwood LLP has advised AM-Pharma on the deal. AM-Pharma signed a €245 million exclusive license agreement deal with Kyowa Kirin, for the development and commercialisation...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here